Bespoke Extracts, Inc. Reports Third Quarter 2025 Results – The Joint Company Scales Colorado Production and Margin Leadership

Core Insights - Bespoke Extracts, Inc. reported record results for Q3 2025, achieving its strongest operational and financial performance to date [1] - The company emphasizes disciplined execution and brand trust as key factors for success in a contracting cannabis market [2][3] Financial Performance - Revenue for Q3 2025 reached $467,945, representing a 68.6% increase year-over-year and a 19.8% increase from Q2 2025 [4][6] - Gross profit was $234,175, up 103.6% from Q3 2024, with a gross margin of 50.0%, an increase of 860 basis points year-over-year [4][6] - Operating expenses decreased by 23.7% compared to Q3 2024, leading to a net loss of $78,088, a 71.7% improvement from the previous year [4][6] Production and Market Strategy - The company produced 209,600 pre-rolls in Q3 2025, an 81% increase year-over-year [6] - Bespoke Extracts aims to replicate its successful model across additional regulated markets, including Massachusetts and New York [10] Future Outlook - Projected revenue for Q4 2025 is between $425,000 and $500,000, indicating a year-over-year growth of 41% to 66% [10] - The company plans to launch two new brands in Q4 to capture adjacent market segments [10]